Cargando…

Reverting doxorubicin resistance in colon cancer by targeting a key signaling protein, steroid receptor coactivator

Although there have been notable improvements in treatments against cancer, further research is required. In colon cancer, nearly all patients eventually experience drug resistance and stop responding to the approved drugs, making treatment difficult. Steroid receptor coactivator (SRC) is an oncogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Sang, Xiao, Gong-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863609/
https://www.ncbi.nlm.nih.gov/pubmed/29581735
http://dx.doi.org/10.3892/etm.2018.5912